integer Archives - Medical Design Sourcing

Integer will exhibit at Heart Rhythm 2023 this week

NEWS RELEASE: Integer to Exhibit at Heart Rhythm 2023, May 19 – 21

Visit Booth #2135 to Learn How Integer’s Strategic Growth and Innovation in Medical Device Manufacturing, Design and Development Capabilities Meets Customers’ Evolving Medtech Needs.

PLANO, TEXAS – Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2023, a Heart Rhythm Society (HRS) educational event and exhibition in New Orleans, LA, from May 19 – 21, 2023.

HRS attendees can visit Integer at booth #2135 to learn more about the company’s breadth and depth of innovative medical device manufacturing, design and development capabilities.

Integer’s trusted solutions are designed specifically to help customers accelerate time to market, strength…

Integer to join medtech leaders at Heart Rhythm 2023

Integer Holdings logo

Integer (NYSE:ITGR) will join industry leaders at Heart Rhythm Society’s (HRS) Heart Rhythm 2023 event this week.

The event takes place in New Orleans between May 19 and May 21. Attendees can visit Integer at booth #2135 to learn about the company’s capabilities in medical device manufacturing, design and development.

Integer offers trusted solutions to help customers accelerate time to market, strengthen innovation, simplify supply chain and scale production. Examples include battery technology, finished leads and implantable pulse generators (IPGs) for cardiac applications. It’s also a leading manufacturer of access and complex catheter access solutions in electrophysiology. This includes guidewires, transseptal access, diagnostic and ablation technologies.

“We are excited to be exhibiting at the HRS conference and showcasing our advanced manufacturing…

Medtech jobs: The world’s largest medical device companies are hiring

Medical device companies are trying to fill thousand of medtech jobs. [Photo by ijeab – stock.adobe.com]

The world’s largest medical device companies are still hiring for medtech jobs despite layoffs in tech and other industries.

Medtech developers — and medtech jobs — are resilient, with the industry’s COVID-19 pandemic performance only bolstering its recession-proof reputation.

That’s not to say there haven’t been job cuts in medtech, led by thousands of layoffs at Philips as it struggles with a massive recall of deadly respiratory devices. But most medical device manufacturers are still hiring, and in some cases they can’t attract enough candidates to fill every vacancy in a tight labor market.

Stryker, for example, grew to approximately 51,000 employees as of the end of 2022, increasing its headcount by nearly 11 percent last year. Boston Scientific reported nearl…

Integer stock down on Q4 prelims, convertible notes plans

Integer Holdings (NYSE: ITGR) stock is down — a day after the medtech contract manufacturing giant released preliminary fourth-quarter numbers.

ITGR shares were down more than 7% to $65.30 apiece by midday today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 9%.

Plano, Texas–based Integer said it expects fourth-quarter 2022 sales in the $370–372 million range, an increase of 18–19%. Adjusted to exclude one-time items, EPS were 1.08–1.11.

The results would beat the expectations of Wall Street analysts, who were expecting EPS of $1.01 and sales of $356.45 million.

“Integer delivered fourth quarter and full year 2022 preliminary sales and profit at the high-end of 2022 earnings guidance, while continuing to improve its ability to manage a challenging supply chain environment and deliver results for our customers and the patients they serve,” Integer CEO Joseph Dzied…

‘Integer to exhibit at NANS annual meeting’

'

Integer Holdings logo

\n

Integer (NYSE:ITGR) announced that it plans to exhibit at the North American Neuromodulation Society (NANS) Annual Meeting this week.

\n

Plano, Texas-based Integer’s showcase takes place at the meeting at Caesars Palace Convention Center in Las Vegas. It spans from Jan. 12 to Jan. 14.

\n

The company, situated at booth #525, intends to offer information about its medical device manufacturing, designs nd development capabilities. These include implantable neuromodulation offerings following the acquisition of Oscor in December 2021, according to a news release.

\n

Integer plans to unveil its latest innovations in neuromodulation. It said these technologies “enable the next-generation of miniaturized active implantable devices.”

\n

Other offerings Integer will display include its new Xcellion Gen-3 fast-charge lithium-ion implantable battery technology…

Integer to exhibit at NANS annual meeting

Integer Holdings logo

Integer (NYSE:ITGR) announced that it plans to exhibit at the North American Neuromodulation Society (NANS) Annual Meeting this week.

Plano, Texas-based Integer’s showcase takes place at the meeting at Caesars Palace Convention Center in Las Vegas. It spans from Jan. 12 to Jan. 14.

The company, situated at booth #525, intends to offer information about its medical device manufacturing, designs nd development capabilities. These include implantable neuromodulation offerings following the acquisition of Oscor in December 2021, according to a news release.

Integer plans to unveil its latest innovations in neuromodulation. It said these technologies “enable the next-generation of miniaturized active implantable devices.”

Other offerings Integer will display include its new Xcellion Gen-3 fast-charge lithium-ion implantable battery technology. It featu…

Integer Q3 results mixed amid supply chain challenges

Integer Holdings (NYSE:ITGR) today reported third-quarter results that beat The Street on earnings but missed on revenue amid continued supply chain challenges.

The Plano, Texas–based medtech contract manufacturing giant had already warned investors early this month. It reported that deteriorating delivery performance and missed commitments from three suppliers would impact Q3 sales by $15 million. In addition, Integer reduced its full-year guidance.

With the supply chain difficulties already priced in, ITGR shares were slightly up this morning, trading at $60.33 apiece. (Integer’s stock is down more than 1% over the past month.) MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 1%.

Integer earned $16 million, or 48¢ per share, off $343 million in sales for the quarter ended Sept. 30, 2022, with the bottom-line down 27% and the top-line up 12% compared with Q3 2021. Read more

Integer revises 2022 outlook amid supply chain woes

Integer (NYSE:ITGR) announced yesterday that it is revising its 2022 financial outlook due to the negative impact of the supply chain environment.

Shares of ITGR took a massive hit today after yesterday’s post-market close announcement. They slid down 12.1% at $58.27 apiece in midday trading.

Plano, Texas-based Integer said in a news release that its customer demand remains strong. However, the “challenging” supply chain situation caused a sales slide.

The company said the issues caused about a $15 million hit on its third-quarter revenues. The primary reason is “deteriorating delivery performance” and missed commitments from three suppliers. The lower sales volume and higher manufacturing costs caused about a $12 million total negative impact on the company’s third-quarter preliminary operating income.

Integer attributed heightened manufacturing costs to increased wages, freight and the addition of 5% more labo…

Integer grows sales 12% in Q2, driven by recent acquisitions

Integer (NYSE:ITGR) posted second-quarter results today that beat the overall consensus forecast on Wall Street.

The Plano, Texas-based medical device outsource manufacturer reported profits of $20.8 million, or 62¢ per share, on sales of $350 million for the three months ended July 1, for a bottom-line loss of 29.2% on sales growth of 12.2% compared with Q2 2021.

Adjusted to exclude one-time items, earnings per share were $1.04, 8¢ ahead of The Street, where analysts were looking for sales of $43.57 million.

“Integer delivered second quarter 2022 financial results consistent with our expectations, as sales grew 13% versus the first quarter 2022 and 12% versus prior year. Integer’s associates around the globe remain focused on delivering products for our customers and the patients they serve, while managing the challenges of the ongoing labor and supply chain dynamics,” President and CEO Joseph Dziedzic said in a news release.

Cardio and vascular …

Integer misses on Q1, adjusts full-year outlook

Holdings (NYSE:ITGR) posted first-quarter results today that fell short of the consensus forecast on Wall Street and adjusted its outlook for the rest of the year to include its recent acquisition of Aran Biomedical.

The Plano, Texas–based medical device contract manufacturing giant reported profits of $11 million, or $0.34 per diluted share, on sales of $311 million for the three months ended April 1, 2022, for a bottom-line decrease of 47% and sales growth of 7% compared with Q1 2021.

Adjusted to exclude one-time items, earnings per share were $0.78, $0.07 short of the Street, where analysts were looking for EPS of $0.85 on sales of $314.57 million.

Get the full story at our sister site, Medical Design & Outsourcing.

Integer misses on Q1, adjusts full-year outlook

Integer Holdings (NYSE:ITGR) posted first-quarter results today that fell short of the consensus forecast on Wall Street and adjusted its outlook for the rest of the year to include its recent acquisition of Aran Biomedical.

The Plano, Texas–based medical device contract manufacturing giant reported profits of $11 million, or $0.34 per diluted share, on sales of $311 million for the three months ended April 1, 2022, for a bottom-line decrease of 47% and sales growth of 7% compared with Q1 2021.

Adjusted to exclude one-time items, earnings per share were $0.78, $0.07 short of the Street, where analysts were looking for EPS of $0.85 on sales of $314.57 million.

The financial results were “consistent with our expectations,” Integer President and CEO Joseph Dziedzic said in a news release.

“Our dedicated associates remain focused on delivering products for our customers and the patients they serve, despite the challenging labor and s…

Integer to exhibit at Heart Rhythm 2022

Integer announced that it will be involved in the exhibitions at Heart Rhythm Society’s 2022 event.

Plano, Texas-based Integer said in a news release that attendees of the HRS 2022 event and exhibition in San Francisco (April 29-May 1) can visit the company’s booth (#1827) to learn more about design, development, manufacturing and platform technologies offered through the combination of Integer and Oscor.

Among Integer’s offerings are market-leading battery technology, finished leads, implantable pulse generators and introduced for cardiac applications. Attendees can also learn about the Destino finished guiding sheaths for OEM branding.

The company will also showcase its vertically integrated contract development and manufacturing solutions for diagnostic mapping catheters and cardiac ablation catheters.

“We’re thrilled to continue strategically expanding our capabilities to not only meet, but exceed our customers’ evolving medt…